Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
A medical expert claims Trump's bruised hand proves he is receiving monthly infusions for possible dementia, linking it to ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi® (lecanemab), has been included in the "Commercial Insurance Innovative Drug List", recently introduced by ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...
Eisai Presents New Data On The Continued And Expanding Benefit Of LEQEMBI(R) (Lecanemab-Irmb) Maintenance Treatment In Early Alzheimer's Disease At CTAD 2025. Eisai Presents New Data on the Continued ...
President Donald Trump’s tiredness, recent MRI and hand bruise suggest he may be taking medication to treat Alzheimer’s ...
First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...
OK Magazine on MSN
Donald Trump's health fuels conspiracy theories as congresswoman claims he's taking Alzheimer's drug
Donald Trump’s health is fueling conspiracy theories. South Los Angeles Congresswoman Sydney Kamlager-Dove claimed that Trump ...
US President Donald Trump publicly proclaimed his 'good memory' during a high-profile event on Sunday, in the face of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback